[HTML][HTML] Incidence and risk of venous thromboembolism in bisphosphonates and selective estrogen receptor modulators treatment in Korea

SY Park, SH Kim, TY Kim, YK Lee, YC Ha… - Journal of Korean … - synapse.koreamed.org
Background Selective estrogen receptor modulators (SERMs) were associated with an
increased risk of venous thromboembolism (VTE) due to the estrogen effect. In this study, we …

Incidence and Risk of Venous Thromboembolism in Bisphosphonates and Selective Estrogen Receptor Modulators Treatment in Korea

SY Park, SH Kim, TY Kim, YK Lee, YC Ha, S Jang… - Journal of Korean … - KoreaMed
Background Selective estrogen receptor modulators (SERMs) were associated with an
increased risk of venous thromboembolism (VTE) due to the estrogen effect. In this study, we …

Incidence and Risk of Venous Thromboembolism in Bisphosphonates and Selective Estrogen Receptor Modulators Treatment in Korea.

SY Park, SH Kim, TY Kim, YK Lee, YC Ha… - Journal of Korean …, 2021 - europepmc.org
Background Selective estrogen receptor modulators (SERMs) were associated with an
increased risk of venous thromboembolism (VTE) due to the estrogen effect. In this study, we …

Incidence and Risk of Venous Thromboembolism in Bisphosphonates and Selective Estrogen Receptor Modulators Treatment in Korea

SY Park, SH Kim, TY Kim, YK Lee… - Journal of Korean …, 2021 - snucm.elsevierpure.com
Background: Selective estrogen receptor modulators (SERMs) were associated with an
increased risk of venous thromboembolism (VTE) due to the estrogen effect. In this study, we …

Incidence and Risk of Venous Thromboembolism in Bisphosphonates and Selective Estrogen Receptor Modulators Treatment in Korea

PS Young, KS Hwa, K Tae-Young, H Yong-Chan… - 2021 - scholarworks.bwise.kr
Background: Selective estrogen receptor modulators (SERMs) were associated with an
increased risk of venous thromboembolism (VTE) due to the estrogen effect. In this study, we …

Incidence and Risk of Venous Thromboembolism in Bisphosphonates and Selective Estrogen Receptor Modulators Treatment in Korea

SY Park, SH Kim, TY Kim, YK Lee… - Journal of Korean …, 2021 - pubmed.ncbi.nlm.nih.gov
Background Selective estrogen receptor modulators (SERMs) were associated with an
increased risk of venous thromboembolism (VTE) due to the estrogen effect. In this study, we …

[PDF][PDF] Incidence and Risk of Venous Thromboembolism in Bisphosphonates and Selective Estrogen Receptor Modulators Treatment in Korea

SY Park, SH Kim, TY Kim, YK Lee, YC Ha… - J Korean …, 2021 - pdfs.semanticscholar.org
Background: Selective estrogen receptor modulators (SERMs) were associated with an
increased risk of venous thromboembolism (VTE) due to the estrogen effect. In this study, we …

Incidence and Risk of Venous Thromboembolism in Bisphosphonates and Selective Estrogen Receptor Modulators Treatment in Korea

PS Young, KS Hwa, K Tae-Young… - Journal of Korean …, 2021 - dbpia.co.kr
Background: Selective estrogen receptor modulators (SERMs) were associated with an
increased risk of venous thromboembolism (VTE) due to the estrogen effect. In this study, we …

[HTML][HTML] Incidence and Risk of Venous Thromboembolism in Bisphosphonates and Selective Estrogen Receptor Modulators Treatment in Korea

SY Park, SH Kim, TY Kim, YK Lee, YC Ha… - Journal of Korean …, 2021 - ncbi.nlm.nih.gov
Background Selective estrogen receptor modulators (SERMs) were associated with an
increased risk of venous thromboembolism (VTE) due to the estrogen effect. In this study, we …

Incidence and Risk of Venous Thromboembolism in Bisphosphonates and Selective Estrogen Receptor Modulators Treatment in Korea

SY Park, SH Kim, TY Kim, YK Lee… - Journal of Korean …, 2021 - khu.elsevierpure.com
Background: Selective estrogen receptor modulators (SERMs) were associated with an
increased risk of venous thromboembolism (VTE) due to the estrogen effect. In this study, we …